Why Goldman Sachs says the DeepSeek plunge doesn't point to the start of a big stock market correction
"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 ...
Moderna’s stock is falling. Goldman Sachs says it’s no longer a buy.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
Why Goldman Sachs says investors should buy the dip in U.S. tech stocks
Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most ...
HEDGE FLOW Stock hedge funds post big one-day drop in DeepSeek rout, say Goldman data
Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...
All Eyes on Microsoft Stock Ahead of Earnings; Here’s What Goldman Sachs Expects
Microsoft (NASDAQ:MSFT) has lagged behind the NASDAQ over the past year but is off to a strong start in 2025, outperforming ...
Moderna slips as Goldman Sachs downgrades on revenue outlook
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
Moderna Stock Falls After Goldman Downgrade. Vaccine Sales Are a Worry.
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Goldman Sachs lifts LandBridge stock target to $73, maintains Buy
Goldman Sachs updated its outlook on LandBridge (NYSE:LB), raising the price target to $73 from the previous $71 while reaffirming a Buy rating on the shares. The stock, currently trading at $65.22, ...
Goldman Sachs Group Insiders Sell US$73m Of Stock, Possibly Signalling Caution
The fact that multiple The Goldman Sachs Group, Inc. insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When ...
Navigating Market Uncertainty: Intrinsic Value of The Goldman Sachs Group Inc
In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash ...